| 摘要 |
FIELD: medicine, pharmaceutics. ^ SUBSTANCE: invention relates to medicine and pharmaceutics and concerns a medical agent for treatment of chronic obstructive lung disease, the agent includes (A) glycopyrrolate and (B) (R)-5-[2-(5,6-diethylindan-2-ylamino)-1-hydroxyetyl] -8-hydroxy-1H-quinolin-2-one in free form or in the form of salt or solvate, with specified amount being intended for simultaneous, sequential or separate administration. ^ EFFECT: agent enhances therapy efficacy. ^ 12 cl, 4 tbl, 233 ex |
